SCHEMBL4609332

SCHEMBL4609332

CC(C)(C#N)NNC(C)(C)C#N

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PDE4A P27815 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11494229 0.90 TP53 (0.36) TP53L3MBTL1
SCHEMBL3338400 0.74
SCHEMBL7852949 0.72
SCHEMBL8179395 0.72
Hydrochloric Acid SCHEMBL7540469 0.72
SCHEMBL5200561 0.69
SCHEMBL16750054 0.67
SCHEMBL10717664 0.67
SCHEMBL3114235 0.67
SCHEMBL10909416 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3765441-B1 PROCESS FOR SYNTHESIZING AZO COMPOUNDS ARKEMA FRANCE (FR) 2024-03-27 EP claimed
EP-3765441-A1 PROCESS FOR SYNTHESIZING AZO COMPOUNDS ARKEMA FRANCE (FR) 2021-01-20 EP claimed
WO-2019175510-A1 PROCESS FOR SYNTHESIZING AZO COMPOUNDS ARKEMA FRANCE (FR) 2019-09-19 WO claimed
EP-2821393-B1 Method for the synthesis of azo compounds ARKEMA FRANCE (FR) 2016-04-06 EP claimed
US-9227926-B2 Method of synthesis of azo compounds ARKEMA FRANCE (FR) 2016-01-05 US claimed
US-20150011738-A1 METHOD OF SYNTHESIS OF AZO COMPOUNDS ARKEMA FRANCE (FR) 2015-01-08 US claimed
EP-2821393-A1 Method for the synthesis of azo compounds ARKEMA FRANCE (FR) 2015-01-07 EP claimed
JP-62164655-A None JP disclosed
US-20260103581-A1 PROCESS FOR GRANULATING AZO COMPOUNDS AND GRANULES OBTAINED ARKEMA FRANCE (FR) 2026-04-16 US disclosed
EP-4598902-A1 METHOD FOR GRANULATING AZO COMPOUNDS, AND RESULTING GRANULES ARKEMA FRANCE (FR) 2025-08-13 EP disclosed
CN-119998261-A Granulating method for azo compounds and granules obtained 阿科玛法国公司 2025-05-13 CN disclosed
WO-2024074779-A1 METHOD FOR GRANULATING AZO COMPOUNDS, AND RESULTING GRANULES ARKEMA FRANCE (FR) 2024-04-11 WO disclosed
EP-3765441-B1 PROCESS FOR SYNTHESIZING AZO COMPOUNDS ARKEMA FRANCE (FR) 2024-03-27 EP disclosed
WO-2000042000-A1 METHOD FOR PREPARING AZOIMINOETHERS AND AZOCARBOXYLIC ACID ESTERS AND NOVEL AZOCARBOXYLIC ACID MIXED ESTERS ATOFINA (FR) 2000-07-20 WO disclosed
EP-0230586-B1 PROCESS FOR PRODUCING AZOIMINO ETHERS WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1991-04-17 EP disclosed
US-4950742-A Process for producing azoimino ethers by oxidation of hydiazonitriles WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1990-08-21 US disclosed
EP-0230586-A1 Process for producing azoimino ethers WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1987-08-05 EP disclosed
JP-S62164655-A PRODUCTION OF AZOIMINO ETHER WAKO PURE CHEM IND LTD 1987-07-21 JP disclosed
US-4059492-A STEAM, DETOXIFICATION, VAPORIZATION ERDOLCHEMIE GMBH (DT) 1977-11-22 US disclosed
US-3984451-A Method for preparing hydrazo-bis-acetonitriles PRODUITS CHIMIQUES UGINE KUHLMANN (FR) 1976-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260103581-A1 PROCESS FOR GRANULATING AZO COMPOUNDS AND GRANULES OBTAINED CYP4B1, FGB, AGL TP53 1586/4885L3MBTL1 4337/4885PDE4A 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.